From post

Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

, , , , , , , , , , , и . J Clin Oncol, 26 (11): 1810-1816 (2008)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

 

Другие публикации лиц с тем же именем

Is the Development of Orientation Selectivity Instructed by Activity?, , и . Journal of Neurobiology, (1999)Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane, , , , , , , , , и 2 other автор(ы). J Clin Oncol, 26 (11): 1810-1816 (2008)Local Correlation-based Circuitry Can Account for Responses to Multi-Grating Stimuli in a Model of Cat V1, , и . Journal of Neurophysiology, (2001)Analysis of Linsker's Simulation of Hebbian Rules, и . Neural Computation, (1990)Opponent Inhibition: A Developmental Model of Layer 4 of the Neocortical Circuit, и . Neuron, (2002)Synaptic Economics: Competition and Cooperation in Synaptic Plasticity. Neuron, 17 (3): 371--374 (сентября 1996)Correlation-based Development of Ocularly Matched Orientation and Ocular Dominance Maps: Determination of Required Input Activities, и . Journal of Neuroscience, 18 (23): 9870--9895 (1998)Effect of treatment with sunitinib malate, a multitargeted tyrosine kinase inhibitor, on circulating plasma levels of VEGF, soluble VEGF receptors 2 and 3, and soluble KIT in patients with metastatic breast cancer, , , , , , , , , и . J Clin Oncol (Meeting Abstracts), 24 (18_suppl): 578 (2006)Experimental and Theoretical Studies of the Organization of Afferents to Single Orientation Columns in Visual Cortex, , , и . Cold Spring Harbor Symposia on Quantitative Biology, LV, стр. 515--527. Cold Spring Harbor Laboratory Press, (1990)Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100, , , , , , , , , и 6 other автор(ы). J.Clin.Oncol., 26 (28): 4672-4678 (2008)